Company Filing History:
Years Active: 1990-2025
Title: **David A. Kidwell: Innovator in Lateral Flow Immunoassays**
Introduction
David A. Kidwell is a prominent inventor located in Alexandria, VA, who has contributed significantly to the field of biomedical technology with a remarkable portfolio of 28 patents. His innovative approaches to lateral flow immunoassays demonstrate both creativity and practical application in improving the sensitivity and efficiency of diagnostic tests.
Latest Patents
Among David A. Kidwell's latest patents is the invention of catalytic particles for signal enhancement in lateral flow immunoassays. This invention provides a method for preparing these particles, which, when reduced in the presence of a protein, enhance the sensitivity of immunoassay tests by catalytically developing dye to detect specific analytes.
Another notable patent involves a delay process for chemical reagent application in lateral flow immunoassays. It introduces a release system using a chemistry release fiber that comprises a permeable membrane and a chemical release agent, allowing for the timed delivery of reagents. This innovation significantly optimizes the functionality of lateral flow tests.
Career Highlights
David A. Kidwell has collaborated with notable institutions such as the United States Navy, enhancing his standing and impact in the field of medical diagnostics. His extensive experience not only highlights his technical capabilities but also emphasizes his commitment to advancing healthcare technologies.
Collaborations
Throughout his career, David has worked alongside colleagues Richard J. Colton and Susan M. Conyers. Their collective expertise reflects a strong team dynamic focused on innovation and practical solutions in the realm of lateral flow immunoassays.
Conclusion
David A. Kidwell stands out as a key figure in the development of innovative solutions for lateral flow immunoassays. His array of patents showcases his dedication to enhancing diagnostic capabilities and improving healthcare outcomes, making him a valuable contributor to the field of biomedical technology.